CIK 0000872912
- Non-accelerated filer
- Smaller reporting company
DELCATH SYSTEMS, INC.
Sign in to watch- Ticker
- DCTH
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 061245881
- Phone
- +1 518-743-8892
- Business address
- 566 QUEENSBURY AVENUE, QUEENSBURY, NY, 12804
- Former names
- DELCATH SYSTEMS, INC., DELCATH SYSTEMS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $488,508
- in 1 filing
Net −$488,508. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-31 | SALAMON STEVEN A J Director | Shares withheld for taxes | +215,000 | $10.00 | $2.1M | 404,500 |
| 2021-03-31 | Rosalind Advisors, Inc. Director | Option exercise | +215,000 | $10.00 | $2.1M | 406,500 |
| 2021-03-31 | Aharon Gil Director | Option exercise | +215,000 | $10.00 | $2.1M | 402,000 |
| 2020-12-11 | MICHEL GERARD J Chief Executive Officer | Purchase | +7,500 | $13.25 | $99K | 7,500 |
| 2020-11-23 | Aharon Gil Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2020-11-23 | Padula Christine See Remarks | Grant or award · Employee Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2020-11-23 | CZEREPAK ELIZABETH Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2020-11-23 | Sylvester John Richard Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2020-11-23 | SALAMON STEVEN A J Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2020-11-23 | Purpura John Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +175,000 | 175,000 | ||
| 2020-11-23 | STOLL ROGER G PHD Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2020-11-19 | Purpura John Chief Operating Officer | Purchase | +1,600 | $12.68 | $20K | 14,721 |
| 2020-11-19 | Purpura John Chief Operating Officer | Purchase | +1,600 | $12.68 | $20K | 14,713 |
| 2020-11-17 | Rosalind Advisors, Inc. Director | Purchase | +2,500 | $12.11 | $30K | 191,500 |
| 2020-11-17 | SALAMON STEVEN A J Director | Purchase | +2,500 | $12.11 | $30K | 189,500 |
| 2020-11-16 | Aharon Gil Director | Purchase | +2,000 | $12.00 | $24K | 187,000 |
| 2020-11-13 | Rosalind Advisors, Inc. Director | Purchase | +4,000 | $11.75 | $47K | 189,000 |
| 2020-11-13 | SALAMON STEVEN A J Director | Purchase | +2,000 | $11.51 | $23K | 187,000 |
| 2020-10-01 | MICHEL GERARD J Chief Executive Officer | Grant or award · Employee Stock Option (right to buyer) | +498,000 | 498,000 | ||
| 2020-05-08 | Purpura John See Remarks | Conversion | +6,500 | 13,121 |
Page 11 of 14 · 271 trades